<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(20)</volume><submitter>Bazarian JJ</submitter><pubmed_abstract>The objective of the current study was to determine the classification accuracy of serum S100B and apolipoprotein (apoA-I) for mild traumatic brain injury (mTBI) and abnormal initial head computed tomography (CT) scan, and to identify ethnic, racial, age, and sex variation in classification accuracy. We performed a prospective, multi-centered study of 787 patients with mTBI who presented to the emergency department within 6 h of injury and 467 controls who presented to the outpatient laboratory for routine blood work. Serum was analyzed for S100B and apoA-I. The outcomes were disease status (mTBI or control) and initial head CT scan. At cutoff values defined by 90% of controls, the specificity for mTBI using S100B (0.899 [95% confidence interval (CI): 0.78-0.92]) was similar to that using </pubmed_abstract><journal>Journal of neurotrauma</journal><pagination>1747-54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4047844</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.</pubmed_title><pmcid>PMC4047844</pmcid><pubmed_authors>Leinhart A</pubmed_authors><pubmed_authors>Bazarian JJ</pubmed_authors><pubmed_authors>Wojcik SM</pubmed_authors><pubmed_authors>He H</pubmed_authors><pubmed_authors>Moynihan R</pubmed_authors><pubmed_authors>Kiechle K</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Ellis GL</pubmed_authors><pubmed_authors>Grant WD</pubmed_authors><pubmed_authors>Triner W</pubmed_authors><pubmed_authors>Khan J</pubmed_authors><pubmed_authors>Moscati R</pubmed_authors><pubmed_authors>Mookerjee S</pubmed_authors><pubmed_authors>Blyth BJ</pubmed_authors><pubmed_authors>Secreti LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.</name><description>The objective of the current study was to determine the classification accuracy of serum S100B and apolipoprotein (apoA-I) for mild traumatic brain injury (mTBI) and abnormal initial head computed tomography (CT) scan, and to identify ethnic, racial, age, and sex variation in classification accuracy. We performed a prospective, multi-centered study of 787 patients with mTBI who presented to the emergency department within 6 h of injury and 467 controls who presented to the outpatient laboratory for routine blood work. Serum was analyzed for S100B and apoA-I. The outcomes were disease status (mTBI or control) and initial head CT scan. At cutoff values defined by 90% of controls, the specificity for mTBI using S100B (0.899 [95% confidence interval (CI): 0.78-0.92]) was similar to that using </description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Oct</publication><modification>2026-05-07T02:47:47.636Z</modification><creation>2019-03-27T01:29:36Z</creation></dates><accession>S-EPMC4047844</accession><cross_references><pubmed>23758329</pubmed><doi>10.1089/neu.2013.2853</doi></cross_references></HashMap>